| Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ... Jama 324 (13), 1307-1316, 2020 | 1294 | 2020 |
| Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 AB Cavalcanti, FG Zampieri, RG Rosa, LCP Azevedo, VC Veiga, ... New England Journal of Medicine 383 (21), 2041-2052, 2020 | 1283 | 2020 |
| A living WHO guideline on drugs for covid-19 A Agarwal, B Rochwerg, F Lamontagne, RAC Siemieniuk, T Agoritsas, ... | 942 | 2022 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial VC Veiga, JAGG Prats, DLC Farias, RG Rosa, LK Dourado, FG Zampieri, ... bmj 372, 2021 | 424 | 2021 |
| Methotrexate and rheumatoid arthritis associated interstitial lung disease PA Juge, JS Lee, J Lau, L Kawano-Dourado, JR Serrano, M Sebastiani, ... European Respiratory Journal 57 (2), 2021 | 174 | 2021 |
| Remdesivir for severe covid-19: a clinical practice guideline B Rochwerg, A Agarwal, L Zeng, YS Leo, JA Appiah, T Agoritsas, ... bmj 370, 2020 | 145 | 2020 |
| A living WHO guideline on drugs to prevent covid-19 F Lamontagne, M Stegemann, A Agarwal, T Agoritsas, R Siemieniuk, ... bmj 372, 2021 | 135 | 2021 |
| A living WHO guideline on drugs for covid-19 R Siemieniuk, B Rochwerg, T Agoritsas, F Lamontagne, YS Leo, ... BMJ: British Medical Journal 370, 1-14, 2020 | 121 | 2020 |
| COALITION COVID-19 Brazil III Investigators: Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome … BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ... Jama 324 (13), 1307-1316, 2020 | 70 | 2020 |
| Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial FG Zampieri, LCP Azevedo, TD Corrêa, M Falavigna, FR Machado, ... Critical Care and Resuscitation 19 (2), 175-182. e8, 2017 | 58 | 2017 |
| Exposure assessment tools for hypersensitivity pneumonitis. An official American Thoracic Society workshop report KA Johannson, H Barnes, AP Bellanger, JC Dalphin, ... Annals of the American Thoracic Society 17 (12), 1501-1509, 2020 | 55 | 2020 |
| Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis L Kawano-Dourado, TJ Doyle, K Bonfiglioli, MVY Sawamura, ... Chest 158 (4), 1546-1554, 2020 | 46 | 2020 |
| Pulmonary involvement in long-term mixed connective tissue disease: functional trends and imaging findings after 10 years L Kawano-Dourado, BG Baldi, FU Kay, OM Dias, TE Gripp, PS Gomes, ... Clin. Exp. Rheumatol 33, 234-240, 2015 | 40 | 2015 |
| Low-versus high-chloride content intravenous solutions for critically ill and perioperative adult patients: a systematic review and meta-analysis L Kawano-Dourado, FG Zampieri, LCP Azevedo, TD Corrêa, M Figueiró, ... Anesthesia & Analgesia 126 (2), 513-521, 2018 | 32 | 2018 |
| Coalition covid‐19 Brazil VI Investigators. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised … VC Veiga BMJ 2021, n84, 2019 | 26 | 2019 |
| Sex and gender in interstitial lung diseases L Kawano-Dourado, MK Glassberg, D Assayag, R Borie, KA Johannson European Respiratory Review 30 (162), 2021 | 25 | 2021 |
| Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features DAS Pereira, OM Dias, GE Almeida, MS Araujo, LB Kawano-Dourado, ... Jornal Brasileiro de Pneumologia 41, 151-160, 2015 | 23 | 2015 |
| Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study RG Rosa, AB Cavalcanti, LCP Azevedo, VC Veiga, D De Souza, ... Intensive Care Medicine 49 (2), 166-177, 2023 | 21 | 2023 |
| Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology J Baddini-Martinez, J Ferreira, S Tanni, LR Alves, BF Cabral Junior, ... Jornal Brasileiro de Pneumologia 46, e20190423, 2020 | 18 | 2020 |
